Empowering the Next Generation: Aurora Announces German Internship Program
Aurora Cannabis (NASDAQ: ACB) (TSX: ACB) has launched an internship program at its EU-GMP facility in Leuna, Germany, partnering with Erfurt University of Applied Sciences. The six-month program targets students from the Horticultural Crop Production course, offering hands-on experience in medical cannabis cultivation.
The program will cover all aspects of medical cannabis production, including cloning, care, harvesting, packaging, and cleaning, along with participation in research and development projects. The Leuna facility is among the few sites in Germany authorized to grow medical cannabis, featuring state-of-the-art indoor cultivation methods and sustainable practices.
According to Michael Simon, President of Aurora Europe (Interim), this initiative aims to provide students with unparalleled industry insights while collaborating with leading experts in the global medical cannabis sector.
Aurora Cannabis (NASDAQ: ACB) (TSX: ACB) ha lanciato un programma di tirocinio nella sua struttura EU-GMP a Leuna, Germania, in collaborazione con l'Università di Scienze Applicate di Erfurt. Il programma di sei mesi è rivolto agli studenti del corso di Produzione di Colture Ortofrutticole, offrendo un'esperienza pratica nella coltivazione della cannabis medicinale.
Il programma coprirà tutti gli aspetti della produzione di cannabis medicinale, inclusi clonazione, cura, raccolta, imballaggio e pulizia, oltre alla partecipazione a progetti di ricerca e sviluppo. La struttura di Leuna è tra i pochi siti in Germania autorizzati a coltivare cannabis medicinale, dotata di metodi di coltivazione indoor all'avanguardia e pratiche sostenibili.
Secondo Michael Simon, Presidente di Aurora Europe (Interim), questa iniziativa mira a fornire agli studenti intuizioni senza precedenti nel settore, collaborando con esperti leader a livello globale nel settore della cannabis medicinale.
Aurora Cannabis (NASDAQ: ACB) (TSX: ACB) ha lanzado un programa de prácticas en su instalación EU-GMP en Leuna, Alemania, en colaboración con la Universidad de Ciencias Aplicadas de Erfurt. El programa de seis meses está dirigido a estudiantes del curso de Producción de Cultivos Hortícolas, ofreciendo experiencia práctica en el cultivo de cannabis medicinal.
El programa abarcará todos los aspectos de la producción de cannabis medicinal, incluida la clonación, el cuidado, la cosecha, el empaquetado y la limpieza, junto con la participación en proyectos de investigación y desarrollo. La instalación de Leuna se encuentra entre los pocos sitios en Alemania autorizados para cultivar cannabis medicinal, con métodos de cultivo interior de última generación y prácticas sostenibles.
Según Michael Simon, Presidente de Aurora Europe (Interim), esta iniciativa tiene como objetivo proporcionar a los estudiantes una visión inigualable de la industria mientras colaboran con expertos líderes en el sector global del cannabis medicinal.
오로라 대마초 (NASDAQ: ACB) (TSX: ACB)가 독일 류나에 위치한 EU-GMP 시설에서 에르푸르트 응용과학대학교와 협력하여 인턴십 프로그램을 시작했습니다. 이 6개월 프로그램은 원예 작물 생산 과정의 학생들을 대상으로 하여 의료용 대마초 재배에 대한 실무 경험을 제공합니다.
프로그램은 클론화, 관리, 수확, 포장, 청소를 포함하여 의료 대마초 생산의 모든 측면을 다루며, 연구 및 개발 프로젝트에 참여할 수 있습니다. 류나 시설은 독일에서 의료용 대마초 재배가 허가된 몇 안 되는 장소 중 하나로, 최신 실내 재배 방법과 지속 가능한 관행을 갖추고 있습니다.
마이클 시몬, 아우로라 유럽의 회장(임시)에 따르면, 이 이니셔티브는 학생들에게 산업 통찰력을 제공하고, 글로벌 의료 대마초 분야의 저명한 전문가들과 협력하는 것을 목표로 하고 있습니다.
Aurora Cannabis (NASDAQ: ACB) (TSX: ACB) a lancé un programme de stage dans son établissement EU-GMP à Leuna, en Allemagne, en partenariat avec l'Université des Sciences Appliquées d'Erfurt. Ce programme de six mois s'adresse aux étudiants du cours de Production de Cultures Horticoles, offrant une expérience pratique dans la culture du cannabis médicinal.
Le programme couvrira tous les aspects de la production de cannabis médicinal, y compris le clonage, les soins, la récolte, l'emballage et le nettoyage, ainsi que la participation à des projets de recherche et de développement. L'établissement de Leuna est l'un des rares sites en Allemagne autorisés à cultiver du cannabis médicinal, avec des méthodes de culture en intérieur à la pointe de la technologie et des pratiques durables.
Selon Michael Simon, Président d'Aurora Europe (Intérim), cette initiative vise à fournir aux étudiants des perspectives inégalées sur l'industrie tout en collaborant avec des experts de premier plan dans le secteur mondial du cannabis médicinal.
Aurora Cannabis (NASDAQ: ACB) (TSX: ACB) hat ein Praktikumsprogramm in seiner EU-GMP-Anlage in Leuna, Deutschland, in Zusammenarbeit mit der Fachhochschule Erfurt, ins Leben gerufen. Das sechsmonatige Programm richtet sich an Studierende des Studiengangs Gartenbau, um praktische Erfahrungen im Anbau von medizinischem Cannabis zu sammeln.
Das Programm deckt alle Aspekte der Produktion von medizinischem Cannabis ab, einschließlich Klonen, Pflege, Ernte, Verpackung und Reinigung, sowie die Teilnahme an Forschungs- und Entwicklungsprojekten. Die Leuna-Anlage gehört zu den wenigen Standorten in Deutschland, die zur Anpflanzung von medizinischem Cannabis autorisiert sind und verwendet modernste Innenanbaumethoden sowie nachhaltige Praktiken.
Michael Simon, Präsident von Aurora Europe (Interim), erklärte, dass diese Initiative darauf abzielt, den Studierenden unvergleichliche Einblicke in die Branche zu bieten und mit führenden Experten im globalen Sektor für medizinisches Cannabis zu kooperieren.
- One of few facilities permitted to grow medical cannabis in Germany
- Strategic investment in workforce development through university partnership
- Strengthens position in German medical cannabis market
- None.
NASDAQ | TSX: ACB
Company Launches Internships at Manufacturing Facility in Leuna,
"We are thrilled to be giving these students the opportunity to collaborate with our leading experts in the global medical cannabis industry, providing them with unparalleled insights and skills," says Michael Simon, President of Aurora Europe (Interim). "We are committed to nurturing talent and fostering a collaborative environment, ensuring that our interns leave with an enriched understanding of the industry and a solid foundation for their professional journeys."
Aurora's domestic cannabis facility located in Leuna,
The six-month internship program will focus on all phases of medical cannabis cultivation, including cloning, care, harvesting, packaging and cleaning. Students will also participate in special research and development projects.
Aurora's proven expertise in not only developing premium medical cannabis products, but in cultivating great talent, both domestically and globally, has allowed the company to maintain its leadership position as the largest global medical cannabis company operating in nationally legal markets.
About Aurora Cannabis Inc.
Aurora is opening the world to cannabis, serving both the medical and consumer markets across
Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB".
Forward Looking Information
This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements regarding the Company's German internship partnership, the Company's expansion of the frontiers of global medical cannabis and investment in future industry leaders, and the Company's continued leadership position as the largest global medical cannabis company operating in nationally legal markets.
These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand in
View original content to download multimedia:https://www.prnewswire.com/news-releases/empowering-the-next-generation-aurora-announces-german-internship-program-302347597.html
SOURCE Aurora Cannabis Inc.
FAQ
What is Aurora Cannabis's new internship program in Germany?
Where is Aurora's German cannabis facility located?
What will students learn during Aurora's German internship program?
How long is Aurora's (ACB) German internship program?
Which university is Aurora partnering with for its German internship program?
